Birdwatch Note
2023-08-12 15:32:42 UTC - NOT_MISLEADING
Ivermectin was not additionally approved against Covid-19, but had been consistently approved for humans in the U.S. since 1990 under off-label uses FDA admitted in court that it is not within its authority to dictate physicians' profession and use of approved drugs https://www.courthousenews.com/ivermectin-proponents-ask-fifth-circuit-to-revive-lawsuit-against-fda/
Written by 51A208310029F328098C5CFC8FF40D77CC42FEB8305EA5554D5060A92AF3075A
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1690331786889342976
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1690385831876338164
- noteId - 1690385831876338164
- participantId -
- noteAuthorParticipantId - 51A208310029F328098C5CFC8FF40D77CC42FEB8305EA5554D5060A92AF3075A Participant Details
- createdAtMillis - 1691854362827
- tweetId - 1690331786889342976
- classification - NOT_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 0
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 1
- trustworthySources - 1
- summary
- Ivermectin was not additionally approved against Covid-19, but had been consistently approved for humans in the U.S. since 1990 under off-label uses FDA admitted in court that it is not within its authority to dictate physicians' profession and use of approved drugs https://www.courthousenews.com/ivermectin-proponents-ask-fifth-circuit-to-revive-lawsuit-against-fda/
Note Status History
| createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
| 2023-08-12 15:32:42 UTC (1691854362827) |
1969-12-31 23:59:59 UTC (-1) |
2023-08-14 02:09:58 UTC (1691978998272) |
NEEDS_MORE_RATINGS | 1969-12-31 23:59:59 UTC (-1) |
Note Ratings
| rated at | rated by | |
| 2023-08-13 19:10:34 -0500 | Rating Details | |
| 2023-08-13 16:56:52 -0500 | Rating Details | |
| 2023-08-13 14:48:09 -0500 | Rating Details | |
| 2023-08-13 12:17:47 -0500 | Rating Details | |
| 2023-08-13 09:55:55 -0500 | Rating Details | |
| 2023-08-13 09:21:08 -0500 | Rating Details | |
| 2023-08-13 07:52:54 -0500 | Rating Details | |
| 2023-08-13 07:31:50 -0500 | Rating Details | |
| 2023-08-13 07:13:42 -0500 | Rating Details | |
| 2023-08-13 06:46:49 -0500 | Rating Details | |
| 2023-08-13 06:33:27 -0500 | Rating Details | |
| 2023-08-13 05:09:48 -0500 | Rating Details | |
| 2023-08-13 03:55:04 -0500 | Rating Details | |
| 2023-08-13 02:56:14 -0500 | Rating Details | |
| 2023-08-13 02:44:55 -0500 | Rating Details | |
| 2023-08-13 01:16:39 -0500 | Rating Details | |
| 2023-08-13 00:44:15 -0500 | Rating Details | |
| 2023-08-13 00:37:47 -0500 | Rating Details | |
| 2023-08-13 00:24:27 -0500 | Rating Details | |
| 2023-08-12 23:35:26 -0500 | Rating Details | |
| 2023-08-12 23:27:07 -0500 | Rating Details | |
| 2023-08-12 22:31:48 -0500 | Rating Details | |
| 2023-08-12 22:14:34 -0500 | Rating Details | |
| 2023-08-12 21:52:03 -0500 | Rating Details | |
| 2023-08-12 21:49:05 -0500 | Rating Details | |
| 2023-08-12 21:41:41 -0500 | Rating Details | |
| 2023-08-12 21:40:05 -0500 | Rating Details | |
| 2023-08-12 21:36:34 -0500 | Rating Details | |
| 2023-08-12 19:53:53 -0500 | Rating Details | |
| 2023-08-12 19:49:45 -0500 | Rating Details | |
| 2023-08-12 19:12:43 -0500 | Rating Details | |
| 2023-08-12 19:05:41 -0500 | Rating Details | |
| 2023-08-12 18:56:59 -0500 | Rating Details | |
| 2023-08-12 18:07:18 -0500 | Rating Details | |
| 2023-08-12 17:45:12 -0500 | Rating Details | |
| 2023-08-12 17:31:19 -0500 | Rating Details | |
| 2023-08-12 17:30:40 -0500 | Rating Details | |
| 2023-08-12 17:22:07 -0500 | Rating Details | |
| 2023-08-12 17:15:25 -0500 | Rating Details | |
| 2023-08-12 17:09:11 -0500 | Rating Details | |
| 2023-08-12 16:47:16 -0500 | Rating Details | |
| 2023-08-12 16:35:54 -0500 | Rating Details | |
| 2023-08-12 16:33:49 -0500 | Rating Details | |
| 2023-08-12 16:33:14 -0500 | Rating Details | |
| 2023-08-12 16:17:16 -0500 | Rating Details | |
| 2023-08-12 16:09:47 -0500 | Rating Details | |
| 2023-08-12 15:59:28 -0500 | Rating Details | |
| 2023-08-12 15:07:36 -0500 | Rating Details | |
| 2023-08-12 14:55:31 -0500 | Rating Details | |
| 2023-08-12 14:50:44 -0500 | Rating Details | |
| 2023-08-12 14:46:27 -0500 | Rating Details | |
| 2023-08-12 14:32:57 -0500 | Rating Details | |
| 2023-08-12 14:21:59 -0500 | Rating Details | |
| 2023-08-12 14:06:38 -0500 | Rating Details | |
| 2023-08-12 13:42:47 -0500 | Rating Details | |
| 2023-08-12 12:36:27 -0500 | Rating Details | |
| 2023-08-12 12:32:50 -0500 | Rating Details | |
| 2023-08-12 11:48:11 -0500 | Rating Details | |
| 2023-08-12 11:48:00 -0500 | Rating Details | |
| 2023-08-12 11:39:04 -0500 | Rating Details | |
| 2023-08-12 11:23:10 -0500 | Rating Details | |
| 2023-08-12 11:20:51 -0500 | Rating Details | |
| 2023-08-12 11:00:01 -0500 | Rating Details | |
| 2023-08-12 10:59:48 -0500 | Rating Details | |
| 2023-08-12 10:40:15 -0500 | Rating Details | |
| 2023-08-12 10:39:15 -0500 | Rating Details | |
| 2023-08-14 14:28:24 -0500 | Rating Details | |
| 2023-08-14 07:12:12 -0500 | Rating Details | |
| 2023-08-13 20:53:29 -0500 | Rating Details | |
| 2023-08-13 19:35:58 -0500 | Rating Details | |
| 2023-08-15 09:58:42 -0500 | Rating Details | |
| 2023-08-18 08:43:02 -0500 | Rating Details | |
| 2023-08-21 17:53:36 -0500 | Rating Details | |
| 2023-08-13 07:43:38 -0500 | Rating Details | |
| 2023-08-13 05:56:30 -0500 | Rating Details | |
| 2023-08-13 05:27:37 -0500 | Rating Details | |
| 2023-08-12 21:49:15 -0500 | Rating Details | |
| 2023-08-12 18:54:51 -0500 | Rating Details | |
| 2023-08-12 18:24:21 -0500 | Rating Details | |
| 2023-08-12 17:56:55 -0500 | Rating Details | |
| 2023-08-12 17:14:31 -0500 | Rating Details | |
| 2023-08-12 16:58:35 -0500 | Rating Details | |
| 2023-08-12 16:14:27 -0500 | Rating Details | |
| 2023-08-12 12:38:30 -0500 | Rating Details | |
| 2023-08-12 12:04:36 -0500 | Rating Details | |
| 2023-08-12 10:40:43 -0500 | Rating Details |